Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Income from Continuing Operations: 2020-2024

Historic Income from Continuing Operations for iSpecimen (ISPC) over the last 5 years, with Dec 2024 value amounting to -$12.9 million.

  • iSpecimen's Income from Continuing Operations fell 65.34% to -$2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.3 million, marking a year-over-year decrease of 26.75%. This contributed to the annual value of -$12.9 million for FY2024, which is 18.55% down from last year.
  • As of FY2024, iSpecimen's Income from Continuing Operations stood at -$12.9 million, which was down 18.55% from -$10.8 million recorded in FY2023.
  • In the past 5 years, iSpecimen's Income from Continuing Operations registered a high of -$4.5 million during FY2020, and its lowest value of -$12.9 million during FY2024.
  • For the 3-year period, iSpecimen's Income from Continuing Operations averaged around -$11.3 million, with its median value being -$10.8 million (2023).
  • Data for iSpecimen's Income from Continuing Operations shows a maximum YoY crashed of 78.04% (in 2021) over the last 5 years.
  • Over the past 5 years, iSpecimen's Income from Continuing Operations (Yearly) stood at -$4.5 million in 2020, then slumped by 78.04% to -$8.0 million in 2021, then dropped by 27.93% to -$10.3 million in 2022, then fell by 5.75% to -$10.8 million in 2023, then decreased by 18.55% to -$12.9 million in 2024.